Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
ID: 353590Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353590

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting proposals for the Global Infectious Disease Research Training Program (D43 Clinical Trial Optional), aimed at enhancing the capacity for infectious disease research in low- and middle-income countries (LMICs) through collaboration with U.S. institutions. This funding opportunity encourages the development of training programs that focus on major endemic diseases, neglected tropical diseases, and infections associated with public health issues in LMICs, while excluding HIV/AIDS. The program seeks to build sustainable research skills among trainees, emphasizing mentorship and ethical research practices, with funding available for up to five years and budgets capped at $230,000 for new awards. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for August 6, 2026.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-174-Full-Announcement.html
    PAR-24-174.html
    The Department of Health and Human Services is soliciting proposals for the Global Infectious Disease Research Training Program (D43 Clinical Trial Optional), aimed at fostering collaboration between low- and middle-income country (LMIC) institutions and U.S. organizations to enhance infectious disease research capacity. This funding initiative encourages applications that focus on various prioritized health areas, excluding HIV/AIDS, and aims to develop sustainable research skills among trainees through rigorous training programs embedded in the health priorities of LMICs. Key objectives include providing advanced training, enhancing research independence, and facilitating mentorship relationships to prepare trainees for impactful research careers. The application must demonstrate institutional commitment, outline training strategies, and ensure ethical standards in research. Funding is available for up to five years with budgets capped at $230,000 for new awards, and a application timeline with upcoming deadlines encourages early submissions. The program emphasizes collaboration, capacity building, and research leadership development. Proposals must adhere to strict guidelines and certifications, reflecting the NIH's commitment to enhancing global health through improved research capabilities while addressing infectious diseases affecting resource-poor nations.
    Similar Opportunities
    International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)" aimed at supporting research on infectious diseases in resource-constrained countries. This initiative encourages applications from organizations based in low- and lower-middle-income economies, as classified by the World Bank, and seeks innovative proposals addressing diseases such as HIV/AIDS, tuberculosis, and malaria, with a focus on enhancing local scientific capacity. The total funding available for fiscal year 2024 is approximately $1,360,000, with individual project budgets capped at $125,000 per year for a maximum of five years. Interested applicants can find more information and submission guidelines at the NIH website, with applications accepted until August 1, 2025.
    Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Global Infectious Disease Research Administration Development Award (G11 Clinical Trial Not Allowed), aimed at enhancing the administrative capabilities of research institutions in low- and middle-income countries (LMICs) through advanced training in grants management. This funding opportunity invites eligible institutions to develop comprehensive plans that include a Research Grants Administration/Financial Management Plan, Staff Training Plan, and a Long-term Plan, with the goal of improving oversight and compliance with NIH funding policies. The initiative emphasizes capacity building in resource-limited settings, supporting travel for senior administrators to receive training from experienced U.S. institutions, with project budgets capped at $100,000 annually for a maximum period of two years. Interested applicants should submit their proposals by March 13, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-300.html.
    HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research initiatives focused on HIV-associated non-communicable diseases (NCDs) at low- and middle-income country (LMIC) institutions through the R21 Clinical Trial Optional grant. This program aims to support locally relevant research that explores the relationship between HIV infection and the development of NCDs, enhance research capacity, and foster collaborative networks among researchers in LMICs and the U.S. The grant provides funding up to $275,000 over a two-year period, with a submission deadline of December 8, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Emerging Global Leader Award (K43 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Emerging Global Leader Award (K43), a federal grant aimed at supporting early-career research scientists from low- or middle-income countries (LMICs) to conduct independent clinical trials. Eligible applicants must hold junior faculty positions at LMIC institutions and propose career development activities alongside health-related research projects that align with national priorities, fostering global research collaboration through mentorship from both LMIC and U.S. institutions. This program is crucial for enhancing scientific capacity in LMICs and addressing significant health challenges, providing funding of up to $100,000 for salary and an additional $40,000 per year for research-related expenses over a period of three to five years. The application period opens on November 3, 2024, with a final deadline of December 4, 2026; for more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) to enhance the training of a skilled workforce in biomedical, behavioral, and clinical research, particularly focusing on HIV research. This program aims to support mentoring and hands-on research experiences for participants, including undergraduate and graduate students, medical residents, and early-career faculty, with an emphasis on HIV prevention, health disparities, and neuroscience research. Successful applications must demonstrate a clear educational framework, detailed mentoring plans, and evaluation metrics, with a maximum annual budget of $200,000 available over a project period not exceeding five years. Applications are due by September 7, 2026, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)" to stimulate research aligned with the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative aims to support research on HIV-related comorbidities, gastrointestinal diseases, and metabolic disorders associated with HIV, encouraging applications from a diverse range of organizations, including higher education institutions and non-profits. With an estimated funding of $2 million for fiscal year 2025, the NIH plans to support 3 to 5 selected projects over a maximum project period of five years, with applications undergoing a rigorous peer review process. Interested applicants can find more information and submit their proposals through Grants.gov, with a submission deadline of January 7, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Emerging Global Leader Award (K43), a grant aimed at enhancing the research capacity of early-career scientists from low- and middle-income countries (LMICs). This funding opportunity is designed for junior faculty members at LMIC institutions who propose research aligned with their country's health priorities, while specifically excluding independent clinical trials. The award provides support for up to five years, covering salary and research-related expenses, with the expectation that recipients will dedicate 75% of their time to research and development activities. Interested applicants must submit their proposals by December 3, 2026, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the U.S.-South Africa Program for Collaborative Biomedical Research Phase 3, focusing on HIV/AIDS and related health issues. This funding opportunity aims to foster collaborative research projects between U.S. and South African investigators, emphasizing the development of partnerships that enhance scientific discovery and public health outcomes. With approximately $3.8 million available to support 8-10 awards, eligible applicants must include at least one principal investigator from a recognized South African institution collaborating with a U.S. entity, and applications are due by March 12, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-023.html.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)" aimed at supporting Early Stage Investigators (ESIs) in conducting innovative preclinical research on HIV/AIDS using NHP models. This grant initiative seeks to empower researchers who are within ten years of their terminal degree and have at least two years of postdoctoral experience, enabling them to explore new research directions that align with the NIH Strategic Plan for HIV and HIV-Related Research for FY 2021-2025. The funding provides a maximum of $400,000 over a two-year period, with applications due by September 7, 2025. Interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.